Analysts have been eager to weigh in on the Healthcare sector with new ratings on Dexcom (DXCM), The Ensign Group (ENSG) and Phathom Pharmaceuticals (PHAT).
In a report released yesterday, Marie Thibault from BTIG maintained a Hold rating on Dexcom. The company’s shares closed last Thursday at $421.70.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 70.3% and a 62.0% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Irhythm Technologies, and Edwards Lifesciences.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Dexcom with a $460.78 average price target.
See today’s analyst top recommended stocks >>
The Ensign Group (ENSG)
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on The Ensign Group yesterday and set a price target of $98.00. The company’s shares closed last Thursday at $86.68.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 23.4% and a 74.9% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Community Health, HCA Healthcare, and Addus Homecare.
Currently, the analyst consensus on The Ensign Group is a Strong Buy with an average price target of $97.75.
Phathom Pharmaceuticals (PHAT)
JonesTrading analyst Prakhar Agrawal reiterated a Buy rating on Phathom Pharmaceuticals yesterday. The company’s shares closed last Thursday at $39.81.
According to TipRanks.com, Agrawal is a 1-star analyst with an average return of 0.0% and a 42.9% success rate. Agrawal covers the Healthcare sector, focusing on stocks such as Arcutis Biotherapeutics, Aldeyra Therapeutics, and Ocuphire Pharma.
Phathom Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $61.00, implying a 52.7% upside from current levels. In a report issued on April 14, Needham also assigned a Buy rating to the stock with a $55.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.